Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBMYBristol Myers Squibb
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | BMY | TMO |
|---|
| Close | 63.60 | 648.43 |
| Market Cap | $130B | $240B |
| 1M | −1.59% | +10.75% |
| P/E (TTM) | 14.0 | 34.4 |
| Forward P/E | 10.4 | 21.8 |
| P/E 5-Yr Percentile | 26 | 65 |
| P/S | 2.7 | 5.2 |
| P/B | 5.8 | 4.6 |
| Dividend Yield | 4.58% | 0.29% |
| Latest Quarter Revenue | $13.0B | $12.0B |
| Revenue YoY | +5.7% | +10.5% |
| Gross Margin | 71.3% | — |
| Latest Quarter EPS | 1.62 | 4.68 |
| Avg Post-Earnings Move | ±2.2% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.92% | 2.36% |
| 90-Day Net Insider Buying | −$0.44M | −$38.9M |
BMY · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
